ASPP 2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non‐alcoholic fatty liver disease
Open Access
- 25 September 2014
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 19 (1) , 155-164
Abstract
ASPP 2 is a pro‐apoptotic member of the p53 binding protein family. ASPP 2 has been shown to inhibit autophagy, which maintains energy balance in nutritional deprivation. We attempted to identify the role of ASPP 2 in the pathogenesis of non‐alcoholic fatty liver disease ( NAFLD ). In a NAFLD cell model, control treated and untreated HepG2 cells were pre‐incubated with GFP ‐adenovirus ( GFP ‐ad) for 12 hrs and then treated with oleic acid ( OA ) for 24 hrs. In the experimental groups, the HepG2 cells were pre‐treated with ASPP 2‐adenovirus ( ASPP 2‐ad) or ASPP 2‐si RNA for 12 hrs and then treated with OA for 24 hrs. BALB /c mice fed a methionine‐ and choline‐deficient ( MCD ) diet were used to generate a mouse model of NAFLD . The mice with fatty livers in the control group were pre‐treated with injections of GFP ‐ad for 10 days. In the experimental group, the mice that had been pre‐treated with ASPP 2‐ad were fed an MCD diet for 10 days. ASPP 2‐ad or GFP ‐ad was administered once every 5 days. Liver tissue from fatty liver patients and healthy controls were used to analyse the role of ASPP 2. Autophagy, apoptosis markers and lipid metabolism mediators, were assessed with confocal fluorescence microscopy, immunohistochemistry, western blot and biochemical assays. ASPP 2 overexpression decreased the triglyceride content and inhibited autophagy and apoptosis in the HepG2 cells. ASPP 2‐ad administration suppressed the MCD diet‐induced autophagy, steatosis and apoptosis and decreased the previously elevated alanine aminotransferase levels. In conclusion, ASPP 2 may participate in the lipid metabolism of non‐alcoholic steatohepatitis and attenuate liver failure.Keywords
This publication has 47 references indexed in Scilit:
- Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in miceBMC Gastroenterology, 2013
- Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitorsBMC Infectious Diseases, 2013
- Regulation of ASPP2 Interaction with p53 Core Domain by an Intramolecular Autoinhibitory MechanismPLOS ONE, 2013
- Autophagic activity dictates the cellular response to oncogenic RASProceedings of the National Academy of Sciences, 2012
- Autophagy Releases Lipid That Promotes Fibrogenesis by Activated Hepatic Stellate Cells in Mice and in Human TissuesGastroenterology, 2012
- Differential Roles of Unsaturated and Saturated Fatty Acids on Autophagy and Apoptosis in HepatocytesThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvationProceedings of the National Academy of Sciences, 2010
- Autophagy regulates lipid metabolismNature, 2009
- ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growthGenes & Development, 2006